/

SAB Biotherapeutics

Developing human antibody-based immunotherapies using a bovine platform.

BiotechnologyPharmaceuticals sab.bio ↗

Company facts

Founded: 2014
Employees: 97
Headquarters: United States
Type: Public
Listed: NASDAQ: SABS